This application requests supplemental funding for the Mother / Infant Study of Prevention of Milk-Borne Transmission of HIV in Botswana (R01 HD37793), a randomized, partially placebo-controlled trial being conducted in Botswana that is testing two interventions designed to prevent mother to child transmission (MTCT) of HIV. The primary objectives of the Mother / Infant (""""""""Mashi"""""""") study are: i) To determine whether single-dose maternal and infant nevirapine (NVP, per HIVNET 012 protocol) prevents additional MTCT when added to short-course zidovudine (ZDV, starting at 34 weeks and intrapartum, and for one month to the infant), compared with ZDV alone. ii) To determine whether six months of prophylactic infant ZDV given to breastfeeding infants of HIV-infected mothers compares favorably to formula feeding of infants for six months with regard to MTCT and HIV-free survival among infants randomized to these two different feeding strategies. These important primary objectives have not changed and can be answered (with additional funding) by the Mashi study, which has been preceding very well, with good accrual, minimal loss to follow-up, and excellent data quality. However, the study has undergone several necessary modifications since its inception in order to remain ethical, in response to advances in knowledge of MTCT prevention and in local standards of medical care. One of these changes was the prolongation and intensification of maternal follow-up after findings from Kenya showed that HIV-infected women randomized to breastfeeding suffered three-fold higher mortality than those randomized to formula feeding. The other change is the provision by study staff of combination, potent antiretroviral therapy (ART) to women with AIDS and to all HIV-infected infants in the cohort, to remain in accordance with the new national standard of care in Botswana, which includes ART. These unavoidable and unanticipated changes have resulted in significant increases in the cost of study conduct, primarily due to the additional human resources needed to execute it. ? ?

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
3R01HD037793-05S1
Application #
6798900
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Ryan, Kevin W
Project Start
2000-09-11
Project End
2005-04-30
Budget Start
2004-06-20
Budget End
2005-04-30
Support Year
5
Fiscal Year
2004
Total Cost
$624,000
Indirect Cost
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Balasubramanian, Raji; Fowler, Mary Glenn; Dominguez, Kenneth et al. (2017) Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1. AIDS 31:2465-2474
Powis, Kathleen M; Smeaton, Laura; Hughes, Michael D et al. (2016) In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. AIDS 30:211-20
Russell, Elizabeth S; Mohammed, Terence; Smeaton, Laura et al. (2014) Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity. PLoS One 9:e89928
Lin, Nina H; Smeaton, Laura M; Giguel, Françoise et al. (2011) Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana. J Acquir Immune Defic Syndr 57:46-50
Dryden-Peterson, Scott; Shapiro, Roger L; Hughes, Michael D et al. (2011) Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. J Acquir Immune Defic Syndr 56:428-36
Powis, Kathleen M; Smeaton, Laura; Ogwu, Anthony et al. (2011) Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr 56:131-8
Lin, Nina H; Negusse, Daniel M; Beroukhim, Rameen et al. (2010) The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates. J Virol Methods 169:39-46
Novitsky, Vladimir; Wang, Rui; Bussmann, Hermann et al. (2010) HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the ""test-and-treat"" approach to reduce HIV transmission. PLoS One 5:e10148
Rowley, Christopher F; Boutwell, Christian L; Lee, Esther J et al. (2010) Ultrasensitive detection of minor drug-resistant variants for HIV after nevirapine exposure using allele-specific PCR: clinical significance. AIDS Res Hum Retroviruses 26:293-300
Shapiro, Roger L; Smeaton, Laura; Lockman, Shahin et al. (2009) Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana. J Infect Dis 199:414-8

Showing the most recent 10 out of 21 publications